Discovery of antimicrobial peptides with notable antibacterial potency by an LLM-based foundation model
Science Advances · 07.03.2025 · 11 (10)
DOI: 10.1126/sciadv.ads8932 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 07.03.2025. Verfasst von Jike Wang und 18 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, Zhejiang, China. Hauptthemen laut MEDLINE: Antimicrobial Peptides, Anti-Bacterial Agents, Drug Discovery. Die Arbeit wurde bisher 125-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Large language models (LLMs) have shown remarkable advancements in chemistry and biomedical research, acting as versatile foundation models for various tasks. We introduce AMP-Designer, an LLM-based approach, for swiftly designing antimicrobial peptides (AMPs) with desired properties. Within 11 days, AMP-Designer achieved the de novo design of 18 AMPs with broad-spectrum activity against Gram-negative bacteria. In vitro validation revealed a 94.4% success rate, with two candidates demonstrating exceptional antibacterial efficacy, minimal hemotoxicity, stability in human plasma, and low potential to induce resistance, as evidenced by significant bacterial load reduction in murine lung infection experiments. The entire process, from design to validation, concluded in 48 days. AMP-Designer excels in creating AMPs targeting specific strains despite limited data availability, with a top candidate displaying a minimum inhibitory concentration of 2.0 micrograms per milliliter against Propionibacterium acnes . Integrating advanced machine learning techniques, AMP-Designer demonstrates remarkable efficiency, paving the way for innovative solutions to antibiotic resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, Zhejiang, China.
- CarbonSilicon AI Technology Co. Ltd., Hangzhou 310018, Zhejiang, China.
- School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, Guangdong, China.
- John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138, USA.
- World Tea Organization, Cambridge, MA 02139, USA.
- Department of Materials Science and Engineering, Stanford University, Stanford, CA 94305, USA.
ORCID-Profile: Jike Wang, Jianwen Feng, Yu Kang, Peichen Pan, Jingxuan Ge, Mingyang Wang, Xingcai Zhang, Xujun Zhang, Yafeng Deng, Chang-Yu Hsieh, Zhihui Jiang, Tingjun Hou
Zitieren
APA
Wang, J., Feng, J., Kang, Y., Pan, P., Ge, J., Wang, Y., Wang, M., Wu, Z., Zhang, X., Yu, J., Zhang, X., Wang, T., Wen, L., Yan, G., Deng, Y., Shi, H., Hsieh, C. Y., Jiang, Z., & Hou, T. (2025). Discovery of antimicrobial peptides with notable antibacterial potency by an LLM-based foundation model. Science Advances, 11(10). https://doi.org/10.1126/sciadv.ads8932
Vancouver
Wang J, Feng J, Kang Y, Pan P, Ge J, Wang Y, et al. Discovery of antimicrobial peptides with notable antibacterial potency by an LLM-based foundation model. Science Advances. 2025;11(10). doi:10.1126/sciadv.ads8932
BibTeX
@article{Wang2025,
author = {Wang, Jike and Feng, Jianwen and Kang, Yu and Pan, Peichen and Ge, Jingxuan and Wang, Yan and Wang, Mingyang and Wu, Zhenxing and Zhang, Xingcai and Yu, Jiameng and Zhang, Xujun and Wang, Tianyue and Wen, Lirong and Yan, Guangning and Deng, Yafeng and Shi, Hui and Hsieh, Chang-Yu and Jiang, Zhihui and Hou, Tingjun},
title = {Discovery of antimicrobial peptides with notable antibacterial potency by an LLM-based foundation model},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {10},
doi = {10.1126/sciadv.ads8932}
}
EUVIMED